Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.

Biotechnology

Psivant Therapeutics

Psivant Therapeutics' headquarters in Boston, MA, United States

This department focuses on advancing scientific knowledge and innovation through research initiatives and experimental analysis.

Research and Development

The Scientific Research and Development team at Psivant Therapeutics is dedicated to leveraging cutting-edge computational and experimental techniques to innovate small molecule therapeutics. By integrating expertise in physics, chemistry, and biology, the team drives the QUAISAR platform to tackle challenging protein targets, enabling breakthroughs in drug design and advancing the company's mission to address previously intractable diseases.

Scientific Research and Development

The Leadership Team at Psivant Therapeutics drives the strategic vision and operational excellence of the company, overseeing the integration of cutting-edge computational biophysics with innovative drug design. Composed of experts in science, business development, and executive leadership, this team ensures that the QUAISAR platform effectively translates breakthrough research into viable small molecule therapeutics targeting difficult protein challenges. Their collaborative efforts aim to foster a culture of scientific rigor and industry influence to position Psivant as a leader in biotechnology.

Leadership Team

The Biology and Molecular Sciences team at Psivant Therapeutics focuses on the integration of biological insights and molecular design to drive the development of innovative small molecule therapeutics. This team employs cutting-edge molecular simulations and experimental biology to explore and validate new drug targets, ultimately aiming to unlock potential therapies for challenging diseases. Their work is essential in bridging the gap between theoretical drug design and practical application in therapeutic development.

Biology and Molecular Sciences

The Engineering Team at Psivant Therapeutics is responsible for developing and maintaining the software infrastructure that supports the QUAISAR platform. They create sophisticated algorithms and tools that integrate physics-driven drug design with biological data, ensuring seamless collaboration between engineering, chemistry, and biology teams. This team leverages cloud technologies to enhance data accessibility and scalability, ultimately accelerating the discovery of novel therapeutics.

Engineering Team

This department focuses on the research and development of biological systems, including protein science and immunology.

��

People (3)

Jobs (0)

Other teams

Scientific Research and Development

Leadership Team

Biology and Molecular Sciences

Engineering Team

Biological Sciences

��������

People (3)

Jobs (0)

Other teams

Scientific Research and Development

Leadership Team

Biology and Molecular Sciences

Engineering Team

Biological Sciences

��